Regulatory Update
|
25 March 2013
0 Likes
Australia’s Therapeutic Goods Administration (TGA) and New Zealand’s Medsafe have announced that a new over–the-counter (OTC) drug process for the evaluation of new and changed OTC medicines will be
Read More...
Latest News
|
5 March 2013
1 Likes
The US Food and Drug Administration (FDA) has released a new draft guidance for industry intended to clarify the types of communication used during the review of medical device product submissions
Read More...
Latest News
|
29 January 2013
0 Likes
The US Food and Drug Administration's (FDA) Science Board—an advisory board focused on the mission and competencies of the agency—will soon meet to start the process of reassessing a landmark 2007
Read More...
Latest News
|
28 January 2013
0 Likes
French regulatory authorities, already reeling from two major scandals involving regulated healthcare products, are now facing yet a third involving an acne and contraceptive drug known as Diane-35.A
Read More...
Latest News
|
3 January 2013
0 Likes
The US Food and Drug Administration (FDA) has released three final guidance documents regarding the submission of nearly all medical device applications made to the agency.The guidance documents,
Read More...
Latest News
|
19 December 2012
0 Likes
When it comes to the review of medical devices, how do you think the US Food and Drug Administration (FDA) is doing? While the question is usually left to be answered in the opinion pages of trade
Read More...
Latest News
Regulatory Update
|
6 November 2012
0 Likes
Australia’s Therapeutic Goods Administration (TGA) has reviewed the comments submitted on its Medicines Labeling and Packaging Review Consultation Paper, released in May 2012, and has identified six
Read More...
Latest News
Regulatory Update
|
5 October 2012
3 Likes
Brazil's national regulatory authority, Anvisa, announced on 4 October a number of steps it has implemented to address the priority public health needs of the country, part of a multi-year
Read More...
Latest News
|
4 October 2012
0 Likes
The US Food and Drug Administration's (FDA) Office of Generic Drugs (OGD) has released a new guideline for its internal review staff on how to handle amendments to generic drug applications.The Manual
Read More...
Latest News
Regulatory Update
|
1 October 2012
0 Likes
Health Canada announced on 28 September the expansion of its pilot project on the use of drug review assessment information from foreign regulatory agencies, such as the European Medicines Agency, in
Read More...